Cell line · CVCL_X633
Sup-T1-CCR5
Cancer cell line, Homo sapiens. Childhood T lymphoblastic lymphoma. 2 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. Sup-T1-CCR5. Cell lines, record CVCL_X633. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_X633
On this page
Cell line
As Cellosaurus gives it.
- Name
- Sup-T1-CCR5
- Accession
- CVCL_X633
- RRID
- RRID:CVCL_X633
- Synonyms
- SupT1/CCR5, SupT1-CCR5
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 8Y
- Category
- Cancer cell line
- Diseases
- Childhood T lymphoblastic lymphoma (NCIt C7210); T-cell non-Hodgkin lymphoma (ORDO Orphanet_171918)
- Derived from
- Pleural effusion (in situ)
- Cell type
- T-cell
- Parent
- SUP-T1 (CVCL_1714)
- Entry created
- 2014-09-05
- Entry updated
- 2024-12-19
Source Cellosaurus
Problems1
| Problem | Cellosaurus's note |
|---|---|
| Caution | There seem to be at least 6 different cell lines derived from Sup-T1 by transfection of human CCR5: Sup-T1-CCR5 (Cellosaurus=CVCL_X633), SupT1.CCR5 (Cellosaurus=CVCL_WU88), SupT1-R5 (Cellosaurus=CVCL_WU89), Sup-T1 CCR5+ H6 (Cellosaurus=CVCL_A9NU), Sup-T1 CCR5+ L23 (Cellosaurus=CVCL_A9NV) and Sup-T1 CCR5+ M10 (Cellosaurus=CVCL_A9NW). |
Source Cellosaurus
Papers2
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Long-acting lenacapavir protects macaques against intravenous challenge with simian-tropic HIV. | EBioMedicine | 2023 | Its Methods give the RRID and name the line | PubMed | |
Ability of the V3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4. | J Virol | 2001 | Cellosaurus cites it | PubMed |
Relatives1
| Relation | Cell line | Accession | Problem |
|---|---|---|---|
| Parent | SUP-T1 | CVCL_1714 |
Source Cell lines
Cell banks0
None in this release.
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_X633
GET https://conductscience.org/api/cell-lines/v1/CVCL_X633/problems